Results 41 to 50 of about 30,227 (301)

Dopaminergic agonist bromocriptin in treatment of diabetes mellitus type 2

Ожирение и метаболизм, 2011
Bromocriptine is a sympatholytic agonist of dopamine receptors, which is now proposed for treatment of type 2 diabetes mellitus. In animal studies bromocriptine elevates the decreased levels of dopamine in hypothalamus and blocks excessive sympathetic ...
O A Gerasimenko, E Pigarova, L K Dzeranova   +2 more
doaj   +1 more source

Severe Hypoglycemia Due To the Administration of Bromocriptine in a Non-Diabetic Patient: A Case Study

Case Reports in Clinical Practice, 2020
The patient was a 24-year-old man with persistent vegetative state following severe traumatic brain injury due to a car accident, who was referred to the emergency department with a generalized tonic-clonic seizure due to severe hypoglycemia. The patient
Saeed Choobkar, Samad Nazarpoor, Mojgan kaviani   +2 more
doaj   +1 more source

Bromocriptine mesylate: Food and Drug Administration approved new approach in therapy of non-insulin dependant diabetes mellitus with poor glycemic control

Journal of Pharmacy and Bioallied Sciences, 2010
Food and Drug Administration (FDA) approved bromocriptine mesylate, a quick release formulation, 0.8 mg tablets, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Yogendra Keche
doaj   +1 more source

Activities of bone morphogenetic proteins in prolactin regulation by somatostatin analogs in rat pituitary GH3 cells [PDF]

, 2011
Involvement of the pituitary BMP system in the modulation of prolactin (PRL) secretion regulated by somatostatin analogs, including octreotide (OCT) and pasireotide (SOM230), and a dopamine agonist, bromocriptine (BRC), was examined in GH3 cells.
Inagaki, Kenichi, Iwasaki, Yasumasa, Makino, Hirofumi, Miyoshi, Tomoko, Nakamura, Eri, Ogura, Toshio, Otsuka, Fumio, Suzuki, Jiro, Tsukamoto, Naoko   +8 more
core   +1 more source

Bromocriptine for the treatment of peripartum cardiomyopathy: welcome on BOARD

European Heart Journal, 2017
Peripartum cardiomyopathy (PPCM), according to the actual definition proposed by the Study Group on PPCM of the Heart Failure Association of the European Society of Cardiology (ESC), is an idiopathic cardiomyopathy frequently presenting with left ...
M. Arrigo, A. Blet, A. Mebazaa
semanticscholar   +1 more source

Bromocriptine monotherapy overcomes prostate cancer chemoresistance in preclinical models

Translational Oncology, 2023
Chemoresistance is a major obstacle in the clinical management of metastatic, castration-resistant prostate cancer (PCa). It is imperative to develop novel strategies to overcome chemoresistance and improve clinical outcomes in patients who have failed ...
Lijuan Bai, Xin Li, Yang Yang, Rui Zhao, Elshaddai Z. White, Alira Danaher, Nathan J. Bowen, Cimona V. Hinton, Nicholas Cook, Dehong Li, Alyssa Y. Wu, Min Qui, Yuhong Du, Haian Fu, Omer Kucuk, Daqing Wu   +15 more
doaj  

Use of apomorphine in Parkinsonian patients with neuropsychiatric complications to oral treatment [PDF]

, 1997
Neuropsychiatric side effects often complicate anti-Parkinsonian therapy and pose a significant problem in the optimal management of idiopathic Parkinson's disease.
Abbott, R.J., Chaudhuri, K.R., Ellis, C, Leigh, P.N., Lemmens, Gilbert, Parkes, J.D., Pye, I.F.   +6 more
core   +2 more sources

Effect of bromocriptine alginate nanocomposite (BANC) on a transgenic Drosophila model of Parkinson's disease

Disease Models & Mechanisms, 2016
The effect of bromocriptine, a dopamine agonist, administered in the form of bromocriptine alginate nanocomposite (BANC) was studied on Parkinson's disease (PD) model flies.
Y. Siddique, Wasi Khan, A. Fatima, Smita Jyoti, Saba Khanam, Falaq Naz, Rahul, Fahad Ali, B. Singh, A. Naqvi   +9 more
semanticscholar   +1 more source

Prolactin [PDF]

, 1977
During an oral glucose tolerance test (OGTT) glucose and insulin levels were measured in 26 patients with prolactin-producing pituitary tumours without growth hormone excess.
A. Renauld, A. Weissmann, A.C. Herrington, A.J. Lostroh, B. Winkler, C.N. Hales, E. Cerasi, E.E. McGarry, F.H. Schmidt, I.B. Rathgeb, J. Tourniaire, J.D. Manns, K. von Werder, K. Werder von, K. Werder von, M. M. C. Landgraf-Leurs, M.O. Thorner, M.W. Sinkoff, P. Berle, P. C. Scriba, R. Hörl, R. Landgraf, R. Landgraf, R.C. Bodo De, Y.N. Sinha   +24 more
core   +1 more source

The mode of action of bromocriptine [PDF]

FEBS Letters, 1981
1. Introduction Bromocriptine, an ergot alkaloid and dopamine agonist, is the treatment of choice for the induction of ovulation and pregnancy in cases of infertility due to both functional and organic hyperprolactinemia, the latter being due to prolactin secreting pituitary adenomas.
D. Weinstein, Joseph G. Schenker, R. Folman, J.H. Slonim, Avraham Hochberg, Nathan de-Groot, I. Gloger   +6 more
openaire   +3 more sources